EyePoint (EYPT) Return on Sales (2010 - 2026)
EyePoint (EYPT) posted Return on Sales of 1.73% for Q1 2026, down 58.37% sequentially from 1.09% in Q4 2025, and down 171.0% YoY from 2.43% in Q1 2025.
EyePoint (EYPT) Return on Sales (2010 - 2026) Analysis & Trends
EyePoint has reported Return on Sales for 17 years, with the latest figure at 1.73% in Q1 2026.
- Quarterly Return on Sales fell 171.0% year-over-year to 1.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4% (down 38.0% YoY) and the FY2025 annual result came in at 0.07%, down 4.0% from the prior year.
- Return on Sales fell to 1.73% in Q1 2026 per EYPT's latest filing, from 1.09% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 1.73% in Q1 2026.
- A 5-year average of 0.24% and a median of 0.04% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2023 and 2026: Return on Sales grew 7 bps in 2023, then slumped 171 bps in 2026.
- Over 5 years, Return on Sales stood at 0.04% in 2022, then surged by 71 bps to 0.01% in 2023, then tumbled by 195 bps to 0.04% in 2024, then plunged by 2952 bps to 1.09% in 2025, then plunged by 58 bps to 1.73% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 1.73%, 1.09%, and 0.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | -1.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.86% |
| Mar 31, 2026 | -1.73% |
| Dec 31, 2025 | -1.09% |
| Sep 30, 2025 | -0.62% |
| Jun 30, 2025 | -0.11% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.08% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.02% |